| Literature DB >> 24900243 |
Katarzyna Kaczanowska1, Karl-Heinz Wiesmüller1, Arnaud-Pierre Schaffner1.
Abstract
A collection of novel aminomethyl-pyridines was designed, synthesized, and investigated as potential inhibitors of DPP-4. Optimization of the screening hit afforded a number of 5-aminomethyl-pyridines with inhibitory activity in the nanomolar range. Selected DPP-4 inhibitors were further evaluated for their selectivity over the closely related peptidase DPP-8. 5-Aminomethyl-4-(2,4-dichloro-phenyl)-6-methyl-pyridine-2-carboxylic acid cyanomethyl-amide showed high potency and excellent DPP-4 selectivity [IC50: 10 (DPP-4) and 6600 nM (DPP-8)] and no toxicity in mammalian cell culture.Entities:
Keywords: Aminomethyl-pyridines; DPP-4; DPP-8; diabetes; incretins; structure−activity relationship
Year: 2010 PMID: 24900243 PMCID: PMC4007959 DOI: 10.1021/ml100200c
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345